Maryland State Retirement & Pension System’s BridgeBio Pharma BBIO Stock Holding History

Maryland State Retirement & Pension System’s Portfolio BBIO Stock Details BBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$678K	Buy	+9,104	New	+$638K	0.01%	756

Other funds holding BBIO

Jupiter Topco New York $245B AUM

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

ACM

Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Maryland State Retirement & Pension System's BBIO Position: Q2 2026 in Review

Maryland State Retirement & Pension System opened a new position in BridgeBio Pharma (BBIO) in Q2 2026: 9,104 shares worth $678K. The stake represents 0.01% of the portfolio and ranks #756 among its holdings.

474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

Maryland State Retirement & Pension System held 9,104 shares of BridgeBio Pharma worth $678K as of Q2 2026.
BridgeBio Pharma was a new Maryland State Retirement & Pension System position in Q2 2026.
BridgeBio Pharma made up 0.01% of Maryland State Retirement & Pension System's portfolio in Q2 2026, its #756 holding.
474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Maryland State Retirement & Pension System's 13F filing for Q2 2026, filed 30 Jul 2026.